menu
    • menu

    Company profile for Moleculin Biotech

    NEW Drugs in Dev: 6
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are highly focused on developing treatments for highly resistant cancers. Our Goal: Reinventing a Cornerstone of Cancer Treatment with the Intent to Provide Safer and More Effective Chemotherapy. We have three core technologies, all of which are based on discoveries made at M.D. Anderson Cancer Center by Dr. Waldemar Priebe and his team. Our clinical stage drugs are Annamycin, a Next Generation Anthracycline being studied f...
    We are highly focused on developing treatments for highly resistant cancers. Our Goal: Reinventing a Cornerstone of Cancer Treatment with the Intent to Provide Safer and More Effective Chemotherapy. We have three core technologies, all of which are based on discoveries made at M.D. Anderson Cancer Center by Dr. Waldemar Priebe and his team. Our clinical stage drugs are Annamycin, a Next Generation Anthracycline being studied for the treatment of relapsed or refractory acute myeloid leukemia, or AML, and WP1066, an Immune/Transcription Modulator targeting brain tumors, pancreatic cancer and AML.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Moleculin BiotechUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5300 Memorial Drive, Suite 950 Houston, TX, 77007
    Telephone
    Telephone
    (713) 300-5160
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://moleculin.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/moleculin-llc
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/moleculinbio?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Moleculin Confirms Annamycin's Safety On Heart In 90-Person Study
    Moleculin Confirms Annamycin's Safety On Heart In 90-Person Study

    13 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/13/3217831/0/en/Moleculin-Reports-Independent-Assessment-Confirms-No-Cardiotoxicity-of-Annamycin-in-90-Subjects.html

    GLOBENEWSWIRE
    13 Jan 2026
    Share Share
    Moleculin: Positive WP1066 Phase 1 Data in Pediatric Brain Tumors
    Moleculin: Positive WP1066 Phase 1 Data in Pediatric Brain Tumors

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3206978/0/en/Moleculin-Announces-Positive-Results-from-Phase-1-Clinical-Trial-Evaluating-WP1066-for-the-Treatment-of-Pediatric-Recurrent-Malignant-Brain-Tumors.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share
    Moleculin Exercises Warrants, Raises $6.8M
    Moleculin Exercises Warrants, Raises $6.8M

    10 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/10/3203165/0/en/Moleculin-Announces-Exercise-of-Warrants-for-6-8-Million-Gross-Proceeds.html

    GLOBENEWSWIRE
    10 Dec 2025
    Share Share
    Moleculin Completes Dosing 45 Patients in MIRACLE AML Trial
    Moleculin Completes Dosing 45 Patients in MIRACLE AML Trial

    09 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202323/0/en/Moleculin-Announces-Completion-of-Treatment-for-the-45-Patients-in-Pivotal-MIRACLE-Phase-3-AML-Trial-on-Pace-for-Q1-2026.html

    GLOBENEWSWIRE
    09 Dec 2025
    Share Share
    Moleculin Announces New Annamycin Collaboration in Brain Tumors
    Moleculin Announces New Annamycin Collaboration in Brain Tumors

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3201521/0/en/Moleculin-Announces-New-Annamycin-Collaboration-in-Brain-Tumors.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share
    Moleculin Announces Reverse Stock Split
    Moleculin Announces Reverse Stock Split

    26 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/26/3195167/0/en/Moleculin-Announces-Reverse-Stock-Split.html

    GLOBENEWSWIRE
    26 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search